BEST BUY CO. INC.
Insider trading
July 12, 2020 at 7:00PM
Richard M. Schulze, beneficial owner
Shares sold: 6,000 Price: $86.64
Date: July 8 Indirectly holds:
27,281,712
BIO-TECHNE INC.
James T. Hippel, CFO
Exercised options: 24,079 Price: $108.49
Shares sold: 24,079 Price: $270.45-$274.52
Date: July 6-7 Directly holds: 9,307
H.B. FULLER CO.
James J. Owens, CEO
Shares sold: 74,079 Price: $42.36-$44.91
Date: June 26-29 Directly holds: 219,866
Nathan D. Weaver, officer
Exercised options: 6,041 Price: $22.27
Shares sold: 6,041 Price: $44.86
Date: June 30 Directly holds: 7,375
C.H. ROBINSON WORLDWIDE INC.
Brian P. Short, director
Shares purchased: 66 Price: $76.76
Date: June 30 Directly holds: 21,738
SURMODICS INc.
Gary R. Maharaj, CEO
Shares sold: 2,000 Price: $43.02
Date: July 1 Directly holds: 141,142
TARGET CORP.
Don H. Liu, officer
Shares sold: 4,000 Price: $120
Date: June 30 Directly holds: 57,865
about the writer
Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among private insurers
